Avoiding pitfalls in antibiotic therapy: the antibiotic stewardship approach

Markus H. Huppertz-Thyssen, Carolina Rodriguez Saavedra
{"title":"Avoiding pitfalls in antibiotic therapy: the antibiotic stewardship approach","authors":"Markus H. Huppertz-Thyssen, Carolina Rodriguez Saavedra","doi":"10.54502/msuceva.v2n2a1","DOIUrl":null,"url":null,"abstract":"The aim of this reflection is to determine the effectiveness and safety of ABS interventions. A strong correlation between antibiotic overuse and the growing worldwide resistance, but also with individual side effects is well established and should open the door to a more personalized approach to anti-infective therapies. Antibiotic resistance is a global public health challenge and is recognized as a global threat to human health by national healthcare agencies, governments, medical societies and the World Health Organization (WHO). The anticipated clinical scenario of Pan- Drug – Resistant (PDR) bacteria is accelerated by antibiotic overuse. In fact, multi- drug – resistance (MDR) is already the cause of severe infections, complications, longer hospital stay and increased mortality in most of the countries. Herein, the techniques of an Antibiotic Stewardship Approach and their stepwise implementation are summarized and highlighted. There is often a general lack of understanding on how to choose the right antibiotic at the right time and in the right dose. This article discusses general principles like the best choice and use of different antibiotic classes, a better use of beta- lactams according to principles of pharmacokinetics, avoidance or limitation of unnecessary combination therapies, shorter courses of therapy without any disadvantage in infection control and the value of PCT monitoring. We hope to contribute to the promotion and implementation of these important therapeutical principles, aiming at the reduction of unnecessary or wrong antibiotic therapies and, so, at the decrease of side effects, mortality and further resistance. \n ","PeriodicalId":270279,"journal":{"name":"Magna Scientia UCEVA","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magna Scientia UCEVA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54502/msuceva.v2n2a1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this reflection is to determine the effectiveness and safety of ABS interventions. A strong correlation between antibiotic overuse and the growing worldwide resistance, but also with individual side effects is well established and should open the door to a more personalized approach to anti-infective therapies. Antibiotic resistance is a global public health challenge and is recognized as a global threat to human health by national healthcare agencies, governments, medical societies and the World Health Organization (WHO). The anticipated clinical scenario of Pan- Drug – Resistant (PDR) bacteria is accelerated by antibiotic overuse. In fact, multi- drug – resistance (MDR) is already the cause of severe infections, complications, longer hospital stay and increased mortality in most of the countries. Herein, the techniques of an Antibiotic Stewardship Approach and their stepwise implementation are summarized and highlighted. There is often a general lack of understanding on how to choose the right antibiotic at the right time and in the right dose. This article discusses general principles like the best choice and use of different antibiotic classes, a better use of beta- lactams according to principles of pharmacokinetics, avoidance or limitation of unnecessary combination therapies, shorter courses of therapy without any disadvantage in infection control and the value of PCT monitoring. We hope to contribute to the promotion and implementation of these important therapeutical principles, aiming at the reduction of unnecessary or wrong antibiotic therapies and, so, at the decrease of side effects, mortality and further resistance.  
避免抗生素治疗中的陷阱:抗生素管理方法
反思的目的是确定ABS干预措施的有效性和安全性。抗生素过度使用与全球范围内日益增长的耐药性之间存在很强的相关性,但也与个体副作用之间存在很强的相关性,这已经得到充分证实,应该为更个性化的抗感染治疗方法打开大门。抗生素耐药性是一项全球性的公共卫生挑战,并被国家卫生保健机构、政府、医学会和世界卫生组织(世卫组织)视为对人类健康的全球性威胁。抗生素的过度使用加速了Pan- Drug - Resistant (PDR)细菌的临床发展。事实上,在大多数国家,多重耐药(MDR)已经成为严重感染、并发症、住院时间延长和死亡率上升的原因。本文总结并强调了抗生素管理方法及其逐步实施的技术。对于如何在正确的时间以正确的剂量选择正确的抗生素,人们往往普遍缺乏了解。本文讨论了不同抗生素类别的最佳选择和使用,根据药代动力学原理更好地使用β -内酰胺类药物,避免或限制不必要的联合治疗,缩短治疗疗程而不影响感染控制以及PCT监测的价值等一般原则。我们希望为促进和实施这些重要的治疗原则做出贡献,旨在减少不必要或错误的抗生素治疗,从而减少副作用、死亡率和进一步的耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信